Compare · ALUR vs MDLN
ALUR vs MDLN
Side-by-side comparison of Allurion Technologies Inc. (ALUR) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALUR and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $58.79B.
- Over the past year, ALUR is down 71.4% and MDLN is up 9.8% - MDLN leads by 81.3 points.
- MDLN has hit the wire 4 times in the past 4 weeks while ALUR has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 4 for ALUR).
PerformanceALUR-53.15%MDLN+9.84%
2025-12-17+0.00%2026-05-01
- Company
- Allurion Technologies Inc.
- Medline Inc.
- Price
- $0.68-5.00%
- $44.76+0.65%
- Market cap
- -
- $58.79B
- 1M return
- +0.00%
- +1.69%
- 1Y return
- -71.44%
- +9.84%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 4
- Recent ratings
- 4
- 25
Latest ALUR
- SEC Form 10-K filed by Allurion Technologies Inc.
- Allurion Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.
- SEC Form 8-K filed by Allurion Technologies Inc.
- Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
- Allurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits
- Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
- Allurion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Allurion Receives U.S. FDA Approval
- Gibbons Brendan M. decreased direct ownership by 15% to 10,408 units (SEC Form 5)
Latest MDLN
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)